Literature DB >> 12864966

New insights into the psychosocial aspects of irritable bowel syndrome.

Richard Lea1, Peter J Whorwell.   

Abstract

Irritable bowel syndrome (IBS) is a common condition varying in severity from trivial to incapacitating. The more severe cases are associated with poor quality of life, absenteeism from work, frequent consultation with medical professionals, and psychosocial distress. Historically the disorder was often considered as purely psychosomatic in origin, but we now know that this is a gross oversimplification. Gastrointestinal disorders are better understood using the biopsychosocial model, which emphasizes the importance of biologic and psychosocial factors. This article reviews the epidemiologic association of IBS with psychological and social stresses and explores how such stresses may influence consulting behavior and outcome. This review also describes physiologic mechanisms that may be involved in IBS and discusses the role of psychological therapies and psychotropic medication in the treatment of this condition.

Entities:  

Mesh:

Year:  2003        PMID: 12864966     DOI: 10.1007/s11894-003-0073-z

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  60 in total

Review 1.  Fundamentals of neurogastroenterology.

Authors:  J D Wood; D H Alpers; P L Andrews
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  The growing case for hypnosis as adjunctive therapy for functional gastrointestinal disorders.

Authors:  Olafur S Palsson; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 3.  Role of thyrotrophin releasing hormone and corticotrophin releasing factor in stress related alterations of gastrointestinal motor function.

Authors:  C Beglinger; L Degen
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

4.  Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness.

Authors:  Wendy M Gonsalkorale; Lesley A Houghton; Peter J Whorwell
Journal:  Am J Gastroenterol       Date:  2002-04       Impact factor: 10.864

5.  Irritable bowel syndrome: the influence of psychological factors on the symptom complex.

Authors:  S Fowlie; M A Eastwood; M J Ford
Journal:  J Psychosom Res       Date:  1992-02       Impact factor: 3.006

Review 6.  Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.

Authors:  J Jailwala; T F Imperiale; K Kroenke
Journal:  Ann Intern Med       Date:  2000-07-18       Impact factor: 25.391

Review 7.  5-Hydroxytryptamine and functional bowel disorders.

Authors:  G J Sanger
Journal:  Neurogastroenterol Motil       Date:  1996-12       Impact factor: 3.598

8.  Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

Authors:  K R Neal; L Barker; R C Spiller
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Terminal ileal mucosal mast cells in irritable bowel syndrome.

Authors:  A P Weston; W L Biddle; P S Bhatia; P B Miner
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

Review 10.  A role for inflammation in irritable bowel syndrome?

Authors:  G Barbara; R De Giorgio; V Stanghellini; C Cremon; R Corinaldesi
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more
  11 in total

Review 1.  Irritable bowel syndrome.

Authors:  Antonella Spinelli
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

2.  Snapshot of an integrated psychosocial gastroenterology service.

Authors:  Sarah W Kinsinger; Sarah Ballou; Laurie Keefer
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 3.  Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.

Authors:  Cristina Stasi; Massimo Rosselli; Massimo Bellini; Giacomo Laffi; Stefano Milani
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

Review 4.  Irritable bowel syndrome: relations with functional, mental, and somatoform disorders.

Authors:  Constanze Hausteiner-Wiehle; Peter Henningsen
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

5.  Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome.

Authors:  Clive H Wilder-Smith; Joan Robert-Yap
Journal:  World J Gastroenterol       Date:  2007-07-21       Impact factor: 5.742

Review 6.  Cognitive-behavioral therapy for the management of irritable bowel syndrome.

Authors:  Qing-Lin Tang; Guo-Yao Lin; Ming-Qing Zhang
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

7.  The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects.

Authors:  Takeshi Kadokura; Martin den Adel; Walter J J Krauwinkel; Tetsuo Takeshige; Akito Nishida
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 3.064

Review 8.  Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights.

Authors:  Sarah W Kinsinger
Journal:  Psychol Res Behav Manag       Date:  2017-07-19

9.  Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill® study.

Authors:  Laura Pirkola; Reijo Laatikainen; Jussi Loponen; Sanna-Maria Hongisto; Markku Hillilä; Anu Nuora; Baoru Yang; Kaisa M Linderborg; Riitta Freese
Journal:  World J Gastroenterol       Date:  2018-03-21       Impact factor: 5.742

10.  Subthreshold Psychiatric Psychopathology in Functional Gastrointestinal Disorders: Can It Be the Bridge between Gastroenterology and Psychiatry?

Authors:  Cristina Stasi; Cristiana Nisita; Sonia Cortopassi; Giorgio Corretti; Dario Gambaccini; Nicola De Bortoli; Bernardo Fani; Natalia Simonetti; Angelo Ricchiuti; Liliana Dell'Osso; Santino Marchi; Massimo Bellini
Journal:  Gastroenterol Res Pract       Date:  2017-10-30       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.